Back

Cardiac structure and function in patients with MASLD varies by liver fibrosis severity

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Imaging in cardiovascular risk assessment (2) Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Anne Marie Reimer Jensen

Herlev-Gentofte University Hospital, Gentofte (Denmark)

7 More presentations in this session

Presentation thumbnail
Linking exercise-induced ventricular ectopy with subclinical myocardial damage in asymptomatic individuals
Professor U. Yuksel (Ankara, TR)
Abstract Slides Video
Presentation thumbnail
Higher disease activity and quality of life impairment are associated with increased carotid plaque in psoriatic arthritis patients
Doctor O. Garza Flores (Monterrey, MX)
Abstract Slides Video
Presentation thumbnail
Coronary inflammation as assessed by pericoronary adipose tissue (PCAT) attenuation in patients with and without standard modifiable cardiovascular risk factors (SMuRFs)
Mr S. Sivakumar (Melbourne, AU)
Abstract Slides Video
Presentation thumbnail
Impact of the peri coronary artery inflammation and Ai based risk predictors using cardiac CTA on the stratification of patients with suspected CAD Insight from the NHS England Chest Pain Pilot
Miss N. Sanfeliu Garces (Milton Keynes, GB)
Abstract Slides Video
Presentation thumbnail
Utility of non-invasive MRI assessment of tenosynovial amyloidosis for early detection of cardiac amyloidosis: UNRAVEL, a pilot study
Mr M. Saldanha (Montreal, CA)
Abstract Slides Video

Access the full session

Session thumbnail
Imaging in cardiovascular risk assessment (2)

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Cardiac structure and function in patients with metabolic-associated steatotic liver disease is modified by sex
thumbnail
Congress Presentation
Nonalcoholic fatty liver disease worsens cardiac repair after myocardial infarction
thumbnail
Congress Presentation
Novel LiverRisk score is associated with adverse outcome in heart failure: insights from the BIOSTAT-CHF study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources